Report : Middle East and Africa Artificial Cervical Intervertebral Disc Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Material (Biopolymer Material and Metal Material) and End User (Hospitals, Ambulatory Surgical Centers, and Others) 

At 16.7% CAGR, the Middle East & Africa Artificial Cervical Intervertebral Disc Market is speculated to be worth US$ 193.33 million by 2028, says Business Market Insights      

According to Business Market Insights’ research, the Middle East & Africa artificial cervical intervertebral disc market was valued at US$ 76.60 million in 2022 and is expected to reach US$ 193.33 million by 2028, registering an annual growth rate of 16.7% from 2022 to 2028. Growing number of product approvals and developments and high market potential in developing economies are the critical factors attributed to the market expansion.                

Companies in the artificial cervical intervertebral disc market are undertaking many research and development activities to introduce innovative products. The new replacement therapies enable the adoption of advanced technologies, strengthening the procedural outcomes. For instance, in April 2021, UD FDA approved NuVasive Simplify Cervical Artificial Disc for two-level cervical total disc replacement (cTDR). Additionally, in August 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies and received the US Food and Drug Administration (FDA) approval for its M6-C artificial cervical disc for patients suffering from cervical disc degeneration. The M6-C artificial cervical disc, a next-generation artificial disc, is developed to replace an intervertebral disc damaged by cervical disc degeneration which also restores physiologic motion to the spine. Moreover, in May 2018, Zimmer Biomet received approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for its Mobi-C Cervical Disc for cervical total disc replacement (cTDR). Mobi-C is the first cervical disc prosthesis approved by the US FDA to reconstruct a cervical disc at one and two levels (C3-C7). Such robust developments are likely to reshape the artificial cervical intervertebral disc market during the forecast period.  

On the contrary, high cost of cervical intervertebral disc surgeries hurdles the growth of Middle East & Africa artificial cervical intervertebral disc market.

The Middle East & Africa artificial cervical intervertebral disc market, based on material, has been bifurcated into biopolymer material and metal material. The biopolymer material segment held 62.5% market share in 2022, amassing US$ 47.85 million. It is projected to garner US$ 119.53 million by 2028 to expand at 16.5% CAGR during 2022–2028.

The Middle East & Africa artificial cervical intervertebral disc market based on end user is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 49.1% market share in 2022, amassing US$ 37.61 million. It is projected to garner US$ 95.79 million by 2028 to expand at 16.9% CAGR during 2022–2028.

Based on country, the Middle East & Africa artificial cervical intervertebral disc market is fragmented into Saudi Arabia, the UAE, South Africa, and rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 46.0% market share in 2022. It was assessed at US$ 35.27 million in 2022 and is likely to hit US$ 88.09 million by 2028, exhibiting a CAGR of 16.5% during the forecast period.  

Key players dominating the Middle East & Africa artificial cervical intervertebral disc market are B. Braun Melsugen AG.; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; Orthofix Medical, Inc.; and Zimmer Biomet Holdings, Inc. among others.

Download Free PDF Brochure